» Articles » PMID: 19965613

Sphingosine Kinase Regulates Oxidized Low Density Lipoprotein-mediated Calcium Oscillations and Macrophage Survival

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 2009 Dec 8
PMID 19965613
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We recently reported that oxidized LDL (oxLDL) induces an oscillatory increase in intracellular calcium ([Ca(2+)](i)) levels in macrophages. Furthermore, we have shown that these [Ca(2+)](i) oscillations mediate oxLDL's ability to inhibit macrophage apoptosis in response to growth factor deprivation. However, the signal transduction pathways by which oxLDL induces [Ca(2+)](i) oscillations have not been elucidated. In this study, we show that these oscillations are mediated in part by intracellular mechanisms, as depleting extracellular Ca(2+) did not completely abolish the effect. Inhibiting sarco-endoplasmic reticulum ATPase (SERCA) completely blocked [Ca(2+)](i) oscillations, suggesting a role for Ca(2+) reuptake by the ER. The addition of oxLDL resulted in an almost immediate activation of sphingosine kinase (SK), which can increase sphingosine-1-phosphate (S1P) levels by phosphorylating sphingosine. Moreover, S1P was shown to be as effective as oxLDL in blocking macrophage apoptosis and producing [Ca(2+)](i) oscillations. This suggests that the mechanism in which oxLDL generates [Ca(2+)](i) oscillations may be 1) activation of SK, 2) SK-mediated increase in S1P levels, 3) S1P-mediated Ca(2+) release from intracellular stores, and 4) SERCA-mediated Ca(2+) reuptake back into the ER.

Citing Articles

oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca /K channel flow.

Su J, Zhou H, Liu X, Nilsson J, Fredrikson G, Zhao M J Cell Mol Med. 2016; 21(5):929-940.

PMID: 27995732 PMC: 5387129. DOI: 10.1111/jcmm.13033.


The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.

Virella G, Lopes-Virella M Front Endocrinol (Lausanne). 2012; 3:76.

PMID: 22715334 PMC: 3375400. DOI: 10.3389/fendo.2012.00076.


Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Blaho V, Hla T Chem Rev. 2011; 111(10):6299-320.

PMID: 21939239 PMC: 3216694. DOI: 10.1021/cr200273u.

References
1.
Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S . Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999; 147(3):545-58. PMC: 2151183. DOI: 10.1083/jcb.147.3.545. View

2.
Xu C, Zhang Y, Stenman E, Edvinsson L . D-erythro-N,N-dimethylsphingosine inhibits bFGF-induced proliferation of cerebral, aortic and coronary smooth muscle cells. Atherosclerosis. 2002; 164(2):237-43. DOI: 10.1016/s0021-9150(02)00100-4. View

3.
Edsall L, Pirianov G, Spiegel S . Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J Neurosci. 1997; 17(18):6952-60. PMC: 6573266. View

4.
Berridge M, Bootman M, Lipp P . Calcium--a life and death signal. Nature. 1998; 395(6703):645-8. DOI: 10.1038/27094. View

5.
Martens J, Lougheed M, Gomez-Munoz A, Steinbrecher U . A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein. J Biol Chem. 1999; 274(16):10903-10. DOI: 10.1074/jbc.274.16.10903. View